Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1861 results about "Influenzavirus" patented technology

A non-taxonomic grouping of the viruses capable of causing the respiratory tract infection commonly called the flu.

RPA-CRISPR / Cas12a-based crRNA for detecting common respiratory viruses, multiple detection kit and application

The invention discloses crRNA for detecting common respiratory viruses based on RPA-CRISPR / Cas12a, a multiple detection kit and application, and relates to the technical field of respiratory virus detection. The crRNA sequence for detecting the novel coronavirus is as shown in SEQ ID NO: 1 or SEQ ID NO: 4; the crRNA sequence for detecting the influenza A virus is as shown in SEQ ID NO: 7; the crRNA sequence for detecting the influenza B virus is as shown in SEQ ID NO: 10; the crRNA sequence for detecting the respiratory syncytial virus is as shown in SEQ ID NO: 13; the crRNA sequence for detecting the parainfluenza virus is as shown in SEQ ID NO: 16. The method has the beneficial effects that a CRISPR-Cas system can be combined with a recombinant polymerase isothermal amplification technology, relatively high sensitivity and specificity are shown in the aspect of improving the reliability of a diagnosis result, and the number of detection targets can be increased by combining a centrifugal micro-fluidic chip.
Owner:HEFEI INSTITUTE OF PHYSICAL SCIENCE CHINESE ACADEMY OF SCIENCES

Monoclonal antibody for identifying canine distemper virus H protein, detection test strip and application

The invention discloses a monoclonal antibody for identifying canine distemper virus H protein, a detection test strip and application. The monoclonal antibody comprises a monoclonal antibody 5-8H or a monoclonal antibody 9-7B and has high specificity and sensitivity, the two antibodies can recognize different epitopes, and a detection test strip can be prepared through a double-antibody sandwich method. Tests prove that the monoclonal antibody provided by the invention has no obvious cross reaction on canine parvovirus, canine adenovirus, canine coronavirus and canine parainfluenza virus in preparation of a colloidal gold test strip for detecting the canine distemper virus, and has good specificity and higher sensitivity.
Owner:HUAZHONG AGRI UNIV

Use of recombinant expressed protein in prevention and / or treatment of respiratory disease

A use of a recombinant expressed protein in prevention and / or treatment of a respiratory disease. Provided is a use of two recombinant expressed proteins in preparation of a drug for prevention and / or treatment of a respiratory disease. The respiratory disease is caused by influenza A virus infection or co-infection of influenza A virus and novel coronavirus. GRFT has an amino acid sequence shown in SEQ ID NO: 1, and GL25E has an amino acid sequence shown in SEQ ID NO: 2. The recombinant protein GRFT and fusion protein GL25E can effectively inhibit the influenza A virus infection, wherein GL25E is formed by coupling an EK1 polypeptide on the basis of GRFT, the recombinant protein GRFT and fusion protein GL25E have good inhibitory activity against influenza A virus, also have good inhibitory activity against the co-infection of influenza virus and novel coronavirus, and can be used in preparation of drugs for prevention and / or treatment of respiratory diseases caused by influenza virus and the co-infection of influenza virus and coronavirus.
Owner:SHANXI JINBO BIO PHARMACEUTICAL CO LTD +1

Nucleic acid composition, kit and detection method for simultaneously and rapidly detecting 16 respiratory pathogens

The invention relates to the technical field of gene engineering, in particular to a nucleic acid composition, a kit and a detection method for simultaneously and rapidly detecting 16 respiratory tract pathogens. The method specifically comprises the following steps: detecting influenza A virus, influenza B virus, novel coronavirus (ORF1ab gene, N gene), haemophilus influenzae, universal human parainfluenza virus, respiratory syncytial virus, human metapneumovirus, enterovirus, mycoplasma pneumoniae, group A streptococcus, bordetella pertussis, common coronavirus, rhinovirus, bocavirus and adenovirus; a forward primer, a reverse primer and a specific fluorescent probe of streptococcus pneumoniae. Through the PCR reaction, whether respiratory tract pathogens exist or not can be rapidly detected from a specimen at the same time, typing identification of 16 respiratory tract pathogens is carried out at the same time, and compared with a single fluorescent quantitative PCR method, the method is more convenient and rapid, and the cost is lower.
Owner:GUANGZHOU SHENGLING MEDICAL TECH CO LTD +1

Anti-influenza A virus NP protein antibody pair and application thereof

The invention relates to the technical field of biomedicine, in particular to an anti-influenza A virus NP protein antibody pair and application thereof. The antibody pair comprises two monoclonal antibodies; the monoclonal antibody comprises a heavy chain variable region and a light chain variable region; one monoclonal antibody in the monoclonal antibody pair is named as a 10G10 antibody, and the other monoclonal antibody is named as a 11F8 antibody. The invention also discloses a nucleic acid molecule for coding the monoclonal antibody and a hybridoma cell strain for secreting the monoclonal antibody. In addition, the invention also discloses a kit for detecting influenza virus protein, which comprises the monoclonal antibody pair, the 10G10 antibody is used as a capture antibody, and the 11F8 antibody is used as a labeled antibody. The antibody for resisting the influenza A virus NP protein provided by the invention has relatively good specificity on the influenza virus protein.
Owner:XIAMEN TONGRENXIN BIO-TECH CO LTD

Freeze-dried PCR reagent and kit for respiratory virus nucleic acid detection

The invention belongs to the technical field of virus detection, and particularly relates to a freeze-dried PCR reagent and kit for respiratory virus nucleic acid detection. Positive control; performing negative control; the reaction freeze-dried powder comprises an optimized buffer system, Taq DNA polymerase, reverse transcriptase, dNTP / dUTP Mix, a freeze-drying protective agent, a specific primer and a probe; the specific primer and the probe comprise an oligonucleotide upstream primer for specifically amplifying an M gene conserved region on an influenza A virus genome; by preparing reaction freeze-dried powder, an oligonucleotide primer, a probe, Taq DNA polymerase, reverse transcriptase, dNTP, an optimized buffer system, a freeze-drying protective additive and the like are prepared into components which stably coexist at normal temperature, the detection performance is consistent with that of a liquid reagent, normal-temperature transportation and storage can be realized, the transportation and storage cost of the fluorescent PCR reagent is greatly reduced, the shelf life is prolonged, and the fluorescent PCR reagent is suitable for industrial production. And operation steps are reduced.
Owner:JIANGSU JIANWEI DIAGNOSTIC TECH CO LTD

Monoclonal antibodies NP5 and NP8 for resisting influenza A virus NP protein and application of monoclonal antibodies NP5 and NP8

The invention discloses monoclonal antibodies NP5 and NP8 for resisting influenza A virus NP protein and application of the monoclonal antibodies NP5 and NP8, and belongs to the technical field of monoclonal antibodies. According to the invention, 19 influenza A virus NP protein monoclonal antibodies are prepared, and the monoclonal antibodies NP5 and NP8 are obtained by screening through ELISA (enzyme-linked immuno sorbent assay) detection and sequencing analysis. The NP5 comprises a light chain CDR2 of which the amino acid sequence is RTS, light chains CDR1 and CDR3 of which the amino acid sequences are shown as SEQ ID NO.3-4, and heavy chains CDR1-3 of which the amino acid sequences are shown as SEQ ID NO.7-9; the NP8 comprises a light chain CDR2 of which the amino acid sequence is LVS, light chains CDR1 and CDR3 of which the amino acid sequences are as shown in SEQ ID NO.12 to SEQ ID NO.13, and heavy chains CDR1-3 of which the amino acid sequences are as shown in SEQ ID NO.16 to SEQ ID NO.18. The invention lays a foundation for preparing an influenza A virus detection kit.
Owner:BAODING GUOLAN BIOTECHNOLOGY CO LTD

Nucleic acid composition for respiratory tract pathogen detection and application thereof

The invention provides a nucleic acid composition for respiratory tract pathogen detection and application thereof, and relates to the technical field of biology. The invention provides a nucleic acid detection composition which has high specificity and can be used for detecting various respiratory pathogens. The composition can be used for detecting influenza B virus, influenza A virus H1N1, influenza A virus H3N2, novel coronavirus N gene, novel coronavirus O gene, respiratory syncytial virus, I-type parainfluenza virus, II-type parainfluenza virus, III-type parainfluenza virus, IV-type parainfluenza virus, rhinovirus, adenovirus, haemophilus influenzae, and the like. The kit has 15 pathogens including streptococcus pneumoniae and staphylococcus aureus, the lower detection limit can be as low as 20 copies / reaction, and the kit plays an important role in rapid detection of respiratory tract pathogens.
Owner:ZHUHAI LIVZON DIAGNOSTICS

Composition for detecting respiratory tract infection related pathogens

The invention belongs to the field of molecular biological detection, and provides a joint detection composition which mainly utilizes a multiple fluorescent PCR analysis method to detect related pathogens, so as to simultaneously realize detection of coronavirus, bordetella pertussis, group A streptococcus, parainfluenza virus, streptococcus pneumoniae, haemophilus influenzae and group B streptococcus in a single-tube reaction system. Or detecting and distinguishing at least four of chlamydia pneumoniae. Meanwhile, the detection sensitivity of the composition is higher and reaches 500 copies / mL, and the detection is more accurate.
Owner:SANSURE BIOTECH INC

Monoclonal antibody aiming at neuraminidase of human influenza virus as well as preparation method and application of monoclonal antibody

ActiveCN119060174Aprevent and/or treat infectionLow detection offlineImmunoglobulins against virusesAntibody ingredientsAntigenNeuraminidase
The invention relates to a monoclonal antibody specifically binding to human influenza virus neuraminidase (NA) or an antigen binding fragment thereof, a related product thereof, and a preparation method and application thereof. According to the present invention, the monoclonal antibody or the antigen binding fragment thereof can be combined with the human influenza virus NA protein with the high affinity, and can neutralize the human influenza virus strain with the high neutralizing activity so as to inhibit the infection, such that the huge potential application value is provided in the clinical treatment, prevention and / or detection of the human influenza virus infection.
Owner:INST OF MICROBIOLOGY CHINESE ACAD OF SCI

Method for preparing chicken immortalized cell line

The invention provides a method for preparing a chicken immortalized cell line. The method comprises the following steps: constructing a plasmid system of conditional over-expression TERT (Telomerase Reverse Transcriptase), carrying out ovarian injection and breeding to obtain a transgenic chicken of the conditional over-expression TERT, and carrying out separation and induction to obtain the chicken immortalized cell line. The obtained chicken immortalized cell line has the characteristics of primary cells and is susceptible to viruses; the method can be used for virus reproduction and detection, influenza virus vaccine production and the like, can obtain immortalized cell lines of all organs and all parts of the chicken in a short time, and has a good application prospect in the vaccine industry.
Owner:CHINA AGRI UNIV

Polypeptide for broad-spectrum inhibition of influenza virus and application of polypeptide in prevention and / or treatment of influenza virus infection

PendingCN119143850Alow sequence homologyhigh mutation barrierPeptide/protein ingredientsDepsipeptidesBiogenic peptideInfluenza a
The invention relates to the technical field of biological medicines, in particular to a polypeptide for broad-spectrum inhibition of influenza viruses and application of the polypeptide in prevention and / or treatment of influenza virus infection. The polypeptide for broad-spectrum inhibition of influenza virus comprises the following selections: (1) an amino acid sequence as shown in SEQ ID NO: 1; (2) an amino acid sequence having at least 50% homology with the amino acid sequence shown in (1); (3) amino acid sequences obtained by replacing and / or deleting and / or increasing at least one amino acid residue at any position in the amino acid sequences shown in (1) and (2); and (4) modifying the amino acid sequences shown in (1), (2) and (3) to obtain amino acid sequences. The invention comprises a peptide sequence, a derivative, a peptide composition and independent or combined application in prevention or treatment of anti-influenza viruses, such as combined medication of the polypeptide or the derivative of the polypeptide and other anti-influenza drugs.
Owner:FUDAN UNIVERSITY +1

Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), influenza a and influenza b

PendingUS20250171862A1Microbiological testing/measurementInfluenza Viruses Type AH influenzae type b
Methods for the rapid detection of the presence or absence of SARS-CoV-2, influenza A and influenza B in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting SARS-CoV-2, influenza A, and influenza B and kits are provided that are designed for the detection of SARS-CoV-2, influenza A and influenza B.
Owner:ROCHE MOLECULAR SYSTEMS INC

Primer, probe composition and kit for detecting H9 subtype AIV and IBV and application

The invention provides a primer, a probe composition and a kit for detecting H9 subtype AIV (avian influenza virus) and IBV (infectious bursal virus) and application, and belongs to the technical field of fluorescence detection. According to the primer and probe composition capable of detecting the H9 subtype avian influenza virus and the avian infectious bronchitis virus, which is designed by the invention, SEQ ID NO.1-6 can be used for specifically detecting the H9 subtype avian influenza virus, the avian infectious bronchitis virus and various branch viruses of the H9 subtype avian influenza virus and the avian infectious bronchitis virus; cross reaction with other common viruses is avoided, the detection sensitivity is high, and the lowest detectable quantities of the two viruses are both 1 copy.
Owner:CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENT

Nanometer antibody aiming at influenza A virus H1N1 subtype NA protein and application thereof

The invention belongs to the technical field of biomedicine, and particularly relates to a nano antibody aiming at influenza A virus H1N1 subtype NA protein and application. The nano antibody comprises an amino acid sequence as shown in SEQ ID NO: 1 or consists of the amino acid sequence as shown in SEQ ID NO: 1. The nano antibody has high affinity, and experimental results show that the antibody can effectively inhibit proliferation of PR8 H1N1 virus in vivo and resist infection of lethal dose virus on mice. Meanwhile, the nano antibody is the first nano antibody which aims at the N1 subtype NA protein and has prevention and treatment effects, the market blank is filled, and the nano antibody can be applied to the fields of laboratory research, biosensor development, clinical diagnosis, infection prevention and treatment and the like. The nano antibody provided by the invention has the advantages of small molecular weight, high stability, low production cost and the like, and has wider application potential and market competitive advantages compared with the traditional IgG antibody.
Owner:SICHUAN UNIV

Formula of influenza virus maintenance fluid as well as preparation method and application of influenza virus maintenance fluid

The invention discloses an influenza virus maintenance fluid formula as well as a preparation method and application thereof, and particularly relates to the technical field of biological medicines. The virus maintenance liquid comprises a DMEM / F-12 basal culture medium and effective components, the effective components comprise amino acids, vitamins, salts, a virus proliferation accelerant and an additive, and the virus proliferation accelerant comprises a yeast extract. According to the invention, an influenza virus subunit ELISA detection kit is established, and an influenza virus maintenance solution formula is developed on the basis of a DMEM / F-12 basic culture medium by taking an ELISA detection result at a culture endpoint as a response value. The virus yield of the influenza virus on the MDCK-v cell matrix can be obviously improved, and the production cost is reduced.
Owner:JIANGSU WALVAX BIOTECHNOLOGY CO LTD

Primer group and kit for simultaneously detecting multiple respiratory pathogen nucleic acids based on twenty-six PCR (Polymerase Chain Reaction)

The invention discloses a primer group and a kit for simultaneously detecting nucleic acids of various respiratory pathogens based on twenty-six PCR (Polymerase Chain Reaction). The kit comprises primer pool freeze-dried powder of influenza A virus (FluA), influenza B virus (FluB), respiratory syncytial virus (RSV), human parainfluenza virus (hPIV), mycoplasma pneumoniae (MP), novel coronavirus (SARS-CoV-2), human respiratory adenovirus (HADV), human respiratory nose / enterovirus (HRV / HEV), bordetella pertussis (BP), human coronavirus (HCoV), human bocavirus (HBoV) and chlamydia pneumoniae (CP), PCR (polymerase chain reaction) freeze-dried powder and a buffer solution. According to the kit, primer system optimization is carried out on various pathogens, brand new primers and probe pools are designed, clinical sensitivity and specificity can be achieved, and meanwhile, the kit is matched with a fully-closed full-automatic detection card box integrating sample treatment and amplification and is suitable for rapid detection of respiratory tract pathogens.
Owner:FLASHDX SHENZHEN INC

Anti-H9N2 subtype avian influenza virus paired monoclonal antibody and immunochromatography test paper and application thereof

The invention belongs to the technical field of biology, and particularly relates to a group of paired monoclonal antibodies for resisting H9N2 subtype avian influenza viruses and a surface enhanced Raman spectroscopy rapid detection test strip established based on the antibodies. The paired monoclonal antibody comprises a labeled antibody 1E9 and a capture antibody 3C10 which are prepared by taking hemagglutinin protein of the H9N2 subtype avian influenza virus as antigens and can be specifically combined with the H9N2 subtype avian influenza virus. According to the invention, an SERS (Surface Enhanced Raman Scattering) probe Au-coated Pt-4ATP is used as a marker and is coupled with a labeled antibody 1E9 to prepare a labeled probe, and the labeled probe is paired with a capture antibody 3C10 to establish an SERS immunochromatography test strip. The test strip has a colorimetric and Raman dual interpretation mode, can be used for qualitative and quantitative detection, has the advantages of strong specificity, high sensitivity, good repeatability and stability and the like, is simple and rapid in clinical detection operation, and provides reliable technical support for on-site rapid screening of subtype viruses.
Owner:LONGHU LAB

Kit for visually detecting H5 subtype avian influenza virus based on RPA-CRISPR / Cas12b system and application

The invention discloses a kit for visually detecting an H5 subtype avian influenza virus based on an RPA-CRISPR / Cas12b system and application of the kit, and belongs to the technical field of molecular detection. The kit comprises an RT-RPA (Reverse Transcription-Recombinase Polymerase Amplification) primer pair and sgRNA1 The RT-RPA primer pair comprises a forward primer with a nucleotide sequence as shown in SEQ ID NO.1 and a reverse primer with a nucleotide sequence as shown in SEQ ID NO.2; and the nucleotide sequence of the sgRNA1 is as shown in SEQ ID NO. 7. According to the kit, nucleic acid amplification and detection are synchronously completed through a tubular reaction system, the detection sensitivity reaches 1 copy / mu L, the coincidence rate with fluorescent RT-PCR is 100%, and no cross reaction exists on H7, H9, NDV and IBV. The kit does not need a complex instrument, is suitable for rapid screening on a basic level site, and provides an efficient solution for prevention and control of avian influenza.
Owner:CHINESE ACAD OF INSPECTION & QUARANTINE

Broad-spectrum influenza A vaccine immunogen composition and application

The invention belongs to the technical field of vaccines and biology, and particularly relates to a broad-spectrum influenza A vaccine immunogen composition and application. The invention provides a nucleic acid molecule for coding an immunogenic peptide, wherein the immunogenic peptide comprises: M2 protein extracellular region (M2e) peptide fragments which are connected in series; a hemagglutinin protein stem region extracellular domain (HA2) peptide fragment derived from an H7N9 influenza virus subtype; multimerization of the motif peptide fragment; and optionally, one or more linker peptide fragments independently located between the peptide fragments, wherein the polynucleotide molecule comprises a coding nucleic acid of each peptide fragment. The broad-spectrum influenza A vaccine can induce an organism to generate antigen-specific immune response, a high-titer antibody can be generated 14 days after last inoculation, the broad-spectrum influenza A vaccine can completely protect and resist attack of various subtype influenza A viruses, and the broad-spectrum influenza A vaccine has a wide application prospect.
Owner:FUDAN UNIVERSITY

CRISPR (clustered regularly interspaced short palindromic repeats) / Cas-based kit for isothermal rapid visual detection of H1N1 influenza virus and mycoplasma pneumoniae and detection method thereof

The invention provides a CRISPR (clustered regularly interspaced short palindromic repeats) / Cas-based kit for isothermal rapid visual detection of H1N1 influenza virus and mycoplasma pneumoniae and a detection method thereof. The kit and the detection method provided by the invention can be used for timely, sensitively and specifically detecting a nucleic acid target in a sample. The invention provides a lateral flow analysis (LFA) detection platform of a three-stage amplification system integrating recombinase polymerase amplification (RPA), CRISPR / Cas12a and catalytic hairpin assembly (CHA) circulation, the detection platform is used for sensitively and accurately detecting mycoplasma pneumoniae DNA (MP DNA) and influenza A virus subtype H1N1RNA (H1N1RNA), and compared with other researches based on an LFA-CRISPR / Cas12a system, the detection platform has the advantages that the detection efficiency is greatly improved, and the detection cost is reduced. According to the kit and the detection method provided by the invention, nucleic acids of two pathogens can be visually detected on a single LFA at the same time, and the sensitivity is high.
Owner:SHANDONG NORMAL UNIV

Monoclonal antibody of avian influenza virus PB2 protein, hybridoma cell, labeled compound, application and medicine

The invention belongs to the field of biology, and discloses a monoclonal antibody of avian influenza virus PB2 protein, the monoclonal antibody comprises a heavy chain variable region and a light chain variable region, and can specifically bind to influenza virus matrix protein PB2, and the amino acid sequence of the heavy chain variable region is as shown in SEQ ID NO.1; the amino acid sequence of the light chain variable region is as shown in SEQ ID NO. 2; the hybridoma cell has relatively high sensitivity and specificity, and can be specifically combined with at least five subtype avian influenza PB2 proteins; meanwhile, the invention also provides application and drugs of the labeled compound, the hybridoma cell and the monoclonal antibody.
Owner:CHINA AGRI UNIV

Forsythia alkaloid B as well as preparation method and anti-inflammatory and antiviral application thereof

The invention discloses fructus forsythiae alkaloid B as well as a preparation method and anti-inflammatory and antiviral application thereof, and belongs to the technical field of medicinal chemistry. The fructus forsythiae alkaloid B is norlabdane diterpenoid alkaloid, the molecular formula of the norlabdane diterpenoid alkaloid is C17H23NO2, and the structural formula is shown in the specification. The fructus forsythiae alkaloid B has the beneficial effects that an innovative extraction and separation process is adopted, the fructus forsythiae alkaloid B is separated from fructus forsythiae fruits, the structure of the fructus forsythiae alkaloid B is novel, and the fructus forsythiae alkaloid B has good anti-inflammatory and anti-H9N2, H5N1 and H1N1 influenza virus activity, so that a new material basis is provided for research on anti-inflammatory activity and anti-virus activity of fructus forsythiae. And # imgabs 0 # fructus forsythiae alkaloid B.
Owner:YANTAI UNIV

Multisubunit RSV, HMPV and HPIV vaccines and therapeutics

The present disclosure relates generally to multisubunit nucleic acids comprising a plurality of polynucleotide sequences, wherein each polynucleotide sequence of the plurality comprises a target sequence, a linker sequence, and a self-assembling sequence, or a linker sequence, a target sequence, a linker sequence, and a self-assembling sequence, or a combination thereof, wherein each polynucleotide sequence of the plurality is connected to an adjacent polynucleotide sequence of the plurality by a cleavage sequence, and wherein the multisubunit nucleic acid further comprises a signal sequence upstream of one or more of the polynucleotide sequences of the plurality, wherein the target sequence is obtained or derived from a respiratory syncytial virus, a metapneumovirus, a human parainfluenza virus, or a combination thereof. The multisubunit nucleic acid encodes a multisubunit peptide.
Owner:POPVAX PTE LTD

Influenza A virus and influenza B virus sandwich method detection reagent and application thereof

The invention provides an influenza A / B virus sandwich method detection reagent. The influenza A / B virus sandwich method detection reagent comprises a pair of influenza A virus antibodies and a pair of influenza B virus antibodies, the pair of influenza A virus antibodies comprises a labeled antibody 19C7 and a coated antibody 27H4, the heavy chain amino acid sequence of the 19C7 antibody is SEQ ID NO: 1, and the light chain amino acid sequence of the 19C7 antibody is SEQ ID NO: 2; the heavy chain amino acid sequence of the 27H4 antibody is SEQ ID NO: 9, and the light chain amino acid sequence of the 27H4 antibody is SEQ ID NO: 10; the pair of influenza B virus antibodies comprises a labeled antibody 10G11 and a coated antibody 23E2, the heavy chain amino acid sequence of the 10G11 antibody is SEQ ID NO: 17, and the light chain amino acid sequence of the 10G11 antibody is SEQ ID NO: 18; the heavy chain amino acid sequence of the 23E2 antibody is SEQ ID NO: 25, and the light chain amino acid sequence of the 23E2 antibody is SEQ ID NO: 26. The sandwich method detection reagent has extremely high specificity and sensitivity.
Owner:XIAMEN KANGJI BIOTECHNOLOGY CO LTD +1

Monoclonal antibody against neuraminidase and application thereof

The invention discloses an anti-neuraminidase human monoclonal antibody obtained through multiple rounds of in-vitro screening and recombination transformation and application of the anti-neuraminidase human monoclonal antibody. The application refers to preparation of products for preventing, detecting or treating influenza viruses. The monoclonal antibody provided by the invention has remarkable neuraminidase inhibitory activity and broad-spectrum influenza virus antigen binding capacity, has excellent prevention and treatment effects on various seasonal influenza viruses, provides a new technical choice for resisting influenza infection, and has important application value.
Owner:SUN YAT SEN UNIVERSITY SHENZHEN +1

Capture probe for detecting whole genome of human parainfluenza virus as well as kit and application thereof

The invention provides a capture probe for detecting a human parainfluenza virus whole genome and a kit and application thereof, and relates to the technical field of gene sequencing. The capture probe composition disclosed by the invention comprises probes of which the sequences are shown as SEQ ID NO. 1 to SEQ ID NO. 947. The capture probe composition disclosed by the invention can fully cover the full-length genome of the human parainfluenza virus type 1-4, and has the characteristics of uniformity, specificity and high capture efficiency on a captured region. According to the method, the whole genome sequence of the human parainfluenza virus can be more economically and efficiently obtained through probe hybridization capture and next-generation sequencing technologies, and the purposes of human parainfluenza virus variation monitoring and virus type traceability can be achieved depending on sequence information.
Owner:STATION OF VIRUS PREVENTION & CONTROL CHINA DISEASES PREVENTION & CONTROL CENT

New avian influenza high-risk host species identification method based on virus sharing entropy

PendingCN120299738AEpidemiological alert systemsTick Borne InfectionsBird flu
The invention relates to the technical field of bird flu host species identification, in particular to a new bird flu high-risk host species identification method based on virus sharing entropy. According to the method, on the basis of spatial distribution prediction of bird flu host species, the bird flu virus sharing entropy of the bird flu host species is calculated species by species according to the overlapping areas of the target host species and all other host species by extracting the distribution area overlapping area of the target host species and any other host species, and the bird flu virus sharing entropy of the bird flu host species is obtained. And quantitatively analyzing the possibility that the target host species and other host species are subjected to avian influenza cross-species transmission infection. By comparing and analyzing the entropy value of the shared entropy of the avian influenza virus, the avian influenza host species with high virus reassortment risk are identified, and a scientific basis is provided for prevention and control of epidemic diseases.
Owner:INST OF GEOGRAPHICAL SCI & NATURAL RESOURCE RES CAS

Biosafe and degradable cerium-based tannic acid nano-enzyme as well as preparation method and application thereof

The invention discloses a biologically safe and degradable cerium-based tannic acid nano-enzyme as well as a preparation method and application thereof. The nano-enzyme can be administrated through a non-invasive nasal cavity. In an area with excessive ROS, thioketone on CeTA-k1tkP is destroyed, PEG is removed, hydrogen bonds of an amino acid sequence are allowed to form beta-sheet, the beta-sheet is accumulated at an inflammation part, and a fiber or network structure is formed. Meanwhile, CeTA-k1tkP shows enzyme-like capacity, ROS is effectively eliminated, inflammation is effectively relieved, and systemic immunosuppression is avoided at the same time. In an influenza A (Flu A) virus or Sendai virus (SeV) mediated viral pneumonia model, CeTA-k1tkP can generate responsive deformation in inflammatory lung tissues, so that the nano-enzyme effectively decomposes ROS (reactive oxygen species). In addition, the CeTA-k1tkP can relieve bacterial inflammation and reduce tissue damage in a mouse viral pneumonia model with secondary bacterial infection.
Owner:TIANJIN MEDICAL UNIV

Application of porcine parainfluenza virus type 5 as expression vector

PendingCN119950692AAntiviralsAntibody medical ingredientsPorcine parainfluenza virusVector vaccine
The invention provides application of a porcine parainfluenza virus type 5 as an expression vector, and belongs to the technical field of biological vaccines. According to the invention, a PIV5 strain separated from diarrhea pigs in Jiangsu Province in China is utilized to construct PIV5 virus infectious clone. The eGFP gene is inserted into a PIV5 infectious cloned virus genome, the recombinant PIV5 virus capable of expressing the green fluorescent protein is successfully rescued, and when the eGFP gene is inserted into a P / M gene spacer region, the expression quantity is the highest, which indicates that an exogenous gene expression cassette can influence the expression level of an exogenous gene, and the P / M gene spacer region is the optimal site for inserting the exogenous gene, so that the recombinant PIV5 virus can be successfully rescued. And a solid foundation is laid for developing a vector vaccine by utilizing the swine PIV5. The porcine parainfluenza virus type 5 can be used as an expression vector to express foreign proteins, can also be used for preparing oral vaccines, and can relieve the stress reaction of pigs in the immune process.
Owner:HARBIN VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES (CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER HARBIN BRANCH CENTER)